Short answer
Sana Biotechnology, Inc. (SANA) filed an 8-K current report with the SEC on April 13, 2026 reporting Item 8.01 (Other Events). Mayo Clinic purchasing 7,507,507 SANA shares at $3.33, generating approximately $25.0 million.
Sana Biotechnology, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- Mayo Clinic purchasing 7,507,507 SANA shares at $3.33, generating approximately $25.0 million
- Mayo can elect another 7,507,507 shares by August 31, 2026, potentially adding approximately $25.0 million
- Proceeds earmarked for SC451 and genetically modified stem-cell-derived islet products covered by Mayo’s royalty rights
- Initial closing expected around April 15, 2026; Mayo lock-up extends at least six months after initial closing
- Cash of $138.4 million at December 31 plus approximately $24.9 million proceeds expected to fund operations into 2027
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Sana Biotechnology, Inc. 8-K filings
Get the next SANA 8-K as it lands
Follow SANA for push alerts, or ask the research agent what this filing means.